Literature DB >> 25778415

Persistent conditioned place preference to cocaine and withdrawal hypo-locomotion to mephedrone in the flatworm planaria.

Claire V Hutchinson1, Jose Prados1, Colin Davidson2.   

Abstract

The purpose of the present study was to determine the effects of exposure to cocaine and mephedrone on conditioned place preference (CPP) and locomotion in the flatworm planaria. Planaria were treated with either cocaine or mephedrone at 1 or 10 μM. Planaria were exposed to 15 min of drug in their non-preferred place (either a rough- or smooth-floored petri dish) on alternate days, and were exposed to normal water in their preferred place on the following day. There were 5 days of conditioning to drug. Planaria were then tested for CPP on day 2, 6 and 13 after withdrawal. We found that animals exhibited CPP to cocaine at both 1 and 10 μM, but not to mephedrone. When examining locomotor activity we found that neither cocaine nor mephedrone treatment showed any evidence of evoking increased motility or locomotor sensitisation. Hypo-motility was seen on the first day of conditioning at concentrations of 10 μM for both cocaine and mephedrone, but had disappeared by the last day of conditioning. Examining chronic withdrawal, only 10 μM mephedrone had a significant effect on motility, decreasing locomotion on day 2 of withdrawal. Taken together we have shown that cocaine evoked CPP in planaria. We have also shown withdrawal depressing effects of mephedrone on motility.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cocaine; Conditioned place preference; Locomotion; Mephedrone; Planaria; Withdrawal

Mesh:

Substances:

Year:  2015        PMID: 25778415     DOI: 10.1016/j.neulet.2015.03.021

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians.

Authors:  Emily Dziedowiec; Sunil U Nayak; Keenan S Gruver; Tyra Jennings; Christopher S Tallarida; Scott M Rawls
Journal:  Neuroscience       Date:  2018-06-27       Impact factor: 3.590

Review 2.  How preclinical studies have influenced novel psychoactive substance legislation in the UK and Europe.

Authors:  Raquel Santos-Toscano; Amira Guirguis; Colin Davidson
Journal:  Br J Clin Pharmacol       Date:  2020-02-23       Impact factor: 4.335

3.  PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects.

Authors:  Ashenafi Mebratu Zewde; Frances Yu; Sunil Nayak; Christopher Tallarida; Allen B Reitz; Lynn G Kirby; Scott M Rawls
Journal:  J Neurosci Methods       Date:  2017-10-16       Impact factor: 2.390

4.  The role of mGlu4 receptors within the nucleus accumbens in acquisition and expression of morphine-induced conditioned place preference in male rats.

Authors:  Zahra Ebrahimi; Nazanin Kahvandi; Alireza Komaki; Seyed Asaad Karimi; Marzieh Naderishahab; Abdolrahman Sarihi
Journal:  BMC Neurosci       Date:  2021-03-21       Impact factor: 3.288

5.  Kratom pharmacology: Clues from planarians exposed to mitragynine.

Authors:  Sarah Uddin; Sonita Wiah; Tony Kim; Mia N Watson; Tyra Jennings; Scott M Rawls
Journal:  Physiol Behav       Date:  2021-06-17

6.  Dissociation of place preference and tolerance responses to sucrose using a dopamine antagonist in the planarian.

Authors:  Rafat A Mohammed Jawad; Claire V Hutchinson; Jose Prados
Journal:  Psychopharmacology (Berl)       Date:  2017-12-02       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.